Literature DB >> 2495837

In vitro binding of [14C]acrylamide to neurofilament and microtubule proteins of rats.

D M Lapadula1, M Bowe, C D Carrington, L Dulak, M Friedman, M B Abou-Donia.   

Abstract

Acrylamide produces a dying back type of neuropathy in which there is an accumulation of neurofilaments in the axons. The in vitro binding of [14C]acrylamide to neurofilament and microtubule proteins obtained from rat spinal cord and brain was investigated. The relative binding to the high and middle molecular weight neurofilament was greater than to the low molecular weight neurofilament, while the rate of binding to MAP-1 (microtubule associated protein-1) and -2 was much greater than to tubulin. The binding rate to a 53 kDa protein which co-purified with the neurofilaments was between those of the middle and high molecular weight neurofilaments while the lowest rate of binding was to glial fibrillary acidic protein. These data indicate that there is a direct binding of acrylamide to cytoskeletal proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495837     DOI: 10.1016/0006-8993(89)90496-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Heterogeneous visceral nerve changes in acrylamide intoxication.

Authors:  G L Ferri; S Zareh; M Sbraccia; L Abelli; N Frontali; D Dahl
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration.

Authors:  J D Stone; A P Peterson; J Eyer; T G Oblak; D W Sickles
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

3.  Acrylamide-induced peripheral neuropathy in normal and neurofilament-deficient Japanese quails.

Authors:  A Takahashi; M Mizutani; C Itakura
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  In vitro binding of [14C]2,5-hexanedione to rat neuronal cytoskeletal proteins.

Authors:  C L Lanning; K R Wilmarth; M B Abou-Donia
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.